Follow
Akash Das
Akash Das
Assistant Professor of Molecular Genetics
Verified email at utsouthwestern.edu
Title
Cited by
Cited by
Year
Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis
A Das, MS Brown, DD Anderson, JL Goldstein, A Radhakrishnan
elife 3, e02882, 2014
3342014
Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection
F Lu, Q Liang, L Abi-Mosleh, A Das, JK De Brabander, JL Goldstein, ...
Elife 4, e12177, 2015
2992015
Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells
A Das, JL Goldstein, DD Anderson, MS Brown, A Radhakrishnan
Proceedings of the National Academy of Sciences 110 (26), 10580-10585, 2013
1212013
CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cellss⃞
JM Brown, S Chung, A Das, GS Shelness, LL Rudel, L Yu
Journal of lipid research 48 (10), 2295-2305, 2007
712007
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1
MN Trinh, F Lu, X Li, A Das, Q Liang, JK De Brabander, MS Brown, ...
Proceedings of the National Academy of Sciences 114 (1), 89-94, 2017
652017
Identification of putative active site residues of ACAT enzymes
A Das, MA Davis, LL Rudel
Journal of lipid research 49 (8), 1770-1781, 2008
502008
Identification of the interaction site within acyl-CoA: cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A
A Das, MA Davis, H Tomoda, S Ômura, LL Rudel
Journal of biological chemistry 283 (16), 10453-10460, 2008
412008
Detection of Startle-Type Epileptic Seizures using Machine Learning Technique
P Balakrishnan, S Hemalatha, DNS Keshav
International Journal of Epilepsy 5 (02), 092-098, 2018
42018
ORIC-114, an orally bioavailable, irreversible kinase inhibitor, has superior brain penetration and antitumor activity in subcutaneous and intracranial NSCLC models
JE Long, S Kim, HY Kim, DG Shin, DH Park, R Warne, A Das, G Hegde, ...
Cancer Research 82 (12_Supplement), 3335-3335, 2022
32022
ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor selectively targets EGFR and HER2 exon20 insertion mutants and regresses intracranial NSCLC xenograft …
MR Junttila, S Kim, Y Lee, H Kim, J Kang, J Seok, J Yoo, Y Lee, DH Seo, ...
Cancer Research 81 (13_Supplement), 1466-1466, 2021
22021
A comparative analysis of intracellular cholesterol esterifying enzymes in mammals
A Das
Wake Forest University, The Bowman Gray School of Medicine, 2009
12009
Selective degradation of mutant PIK3CA promotes increased mutant specificity in a subset of PI3K ATP-competitive inhibitors
L Nguyen, K Edgar, K Song, S Schmidt, V Schutz, N Ishisoko, E Torres, ...
MOLECULAR CANCER RESEARCH 18 (10), 43-43, 2020
2020
Abstract PR03: Selective degradation of mutant PIK3CA promotes increased mutant specificity in a subset of PI3K ATP-competitive inhibitors
L Nguyen, K Edgar, K Song, S Schmidt, V Schutz, N Ishisoko, E Torres, ...
Molecular Cancer Research 18 (10_Supplement), PR03-PR03, 2020
2020
The following manuscript will be submitted to Journal of Biological Chemistry. Stylistic variations are due to the requirements of the journal. A. Das conceived the project …
A Das
A dissertation submitted to the graduate faculty of 1050, 2009
2009
The following manuscript was published in the Journal of Lipid Research 2008 volume 49 pages 1770-1781 and is reprinted with permission. Stylistic variations are due to the …
A Das
A dissertation submitted to the graduate faculty of 1050, 2009
2009
The system can't perform the operation now. Try again later.
Articles 1–15